MCDD could improve the general pathological index of PCOS-IR rats, ease the level of inflammatory factors in vivo, regulate the expression of molecules related to the NF-κB signaling pathway and insulin signaling pathway, and inhibit the expression of LCN-2 molecules. The gene discussed is NFKB1; the disease is polycystic ovary syndrome.